I Hudson

2.2k citations

28 papers · 1.8k indexed · 1 hit paper · h-index 19

Impact in

Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments

Papers in

Oncology 13
- Neutropenia and Cancer Infections 9
- Lung Cancer Research Studies 6
- Cancer Treatment and Pharmacology 4
Reproductive Medicine 3
- Ovarian cancer diagnosis and treatment 3

Co-authors: Giorgio Bolis Jaap Verweij Colin Broom Martin Gore B M Holland John H. Malfetano J Carmichael Robert L. Coleman
Journals: European Journal of Cancer (4 papers)Journal of Clinical Oncology (4 papers)The Oncologist (2 papers)Annals of Oncology (2 papers)Archives of Disease in Childhood (2 papers)
Partner nations: United Kingdom Netherlands Italy

In The Last Decade

I Hudson

28 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. 1997 · 532 citations

Peers

Countries citing papers authored by I Hudson

Since Specialization

Citations

This map shows the geographic impact of I Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Hudson more than expected).

Fields of papers citing papers by I Hudson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Hudson. The network helps show where I Hudson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside I Hudson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I Hudson Line = papers co-authored together I Hudson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use The Oncologist ·Maria Nieto, Pierre Démolis, Dabo Wei, Alexandre Moreau, I Hudson, Eliana. Icochea, Rodger Ross, Tomas Salmonson, Christian Gisselbrecht, David Bowen, Francesco Pignatti	2016	35
2	Regulatory evaluation of Glybera in Europe — two committees, one mission Nature Reviews Drug Discovery ·Daniela Melchiorri, Luca Pani, Paolo Gasparini, Giulio Cossu, Jānis Ancāns, John-Joseph Borg, 利休濱田, Piotr Fiedor, Egbert Flory, I Hudson, Hubert G. M. Leufkens, Jan Müller‐Berghaus, Gopalan Narayanan, 许彦梅, Juris Pokrotnieks, Liang Xia, Tomas Salmonson, Christian K. Schneider	2013	45
3	The European Medicines Agency Review of Pixantrone for the Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non-Hodgkin's B-Cell Lymphomas: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use The Oncologist ·Roger Marques, Eliana. Icochea, I Hudson, Jan Sjöberg, Kristina Dunder, Tomas Salmonson, Christian Gisselbrecht, Edward Laane, Francesco Pignatti	2013	30
4	The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use Haematologica ·María J. Nieto, (unknown), I Hudson, G.P. Parham, David A. Brown, A. C. Fugisawa, Heinrich Schmid, Andrea Valeri, Éric Abadie, Aidan Thomas, Francesco Pignatti	2011	16
5	Percutaneous Coronary Intervention to Anomalous Right Coronary Artery and Retained Piece of Guidewire in the Coronary Vasculature Journal of Interventional Cardiology ·Johannes Wolf, I Hudson, Jan Kovac	2005	6
6	Fulminant liver failure: an indicator of silent myocardial rupture Postgraduate Medical Journal ·智子永川, 元子藤井, E. Avgoustoglou, I Hudson	2004	15
7	Continuous infusion of low-dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer Anti-Cancer Drugs ·L Arnoldo, W.W. ten Bokkel Huinink, Margaret Schot, I Hudson, Jos H. Beijnen	1998	19
8	Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors. PubMed ·C J Gerrits, Howard A. Burris, Jan H.M. Schellens, John R. Eckardt, André Planting, Sánchez Barrios, M.ª Inmaculada Sánchez Barrios, M.ª Inmaculada, G I Rodriguez, Walter J. Loos, V van Beurden, I Hudson, Scott Z. Fields, Daniel D. Von Hoff, Jaap Verweij	1998	34
9	Five days of oral topotecan (hycamtin®), a phase I and pharmacological study in adult patients with solid tumours European Journal of Cancer ·C J Gerrits, Howard A. Burris, Jan H.M. Schellens, M.R. Hestenes, Matthias Burg, G I Rodriguez, V van Beurden, Walter J. Loos, I Hudson, Scott Z. Fields, Jaap Verweij, Daniel D. Von Hoff	1998	56
10	Experience with independent radiological review during a topotecan trial in ovarian cancer Annals of Oncology ·Mar Cervera‐Negueruela, Giorgio Bolis, Martin Gore, W. ten Bokkel Huinink, Jaap Verweij, I Hudson, Raymond Despax, Patricia Talens	1997	26
11	Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors. Journal of Clinical Oncology ·G.J. Creemers, C J Gerrits, John R. Eckardt, Jan H.M. Schellens, Howard A. Burris, André Planting, G I Rodriguez, Walter J. Loos, I Hudson, Colin Broom, Jaap Verweij, Daniel D. Von Hoff	1997	66
12	Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. Journal of Clinical Oncology ·W ten Bokkel Huinink, Martin Gore, J Carmichael, Anderley Gordon, John H. Malfetano, I Hudson, Colin Broom, C Scarabelli, N. Davidson, Carl D. Burkett, Giorgio Bolis, Henric Malmström, Robert L. Coleman, Hermann Erychropel, Jean‐François Héron Hit paper breakdown →	1997	532
13	Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study. Journal of Clinical Oncology ·G.J. Creemers, Giorgio Bolis, M. Gore, Giovanna Scarfone, Ángel J. Lacave, Jean‐Paul Guastalla, Raymond Despax, G. Favalli, Shinji Homma, Simon Van Belle, I Hudson, Jaap Verweij, W.W. ten Bokkel Huinink	1996	331
14	Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer. Journal of Clinical Oncology ·G.J. Creemers, C J Gerrits, Jan H.M. Schellens, André Planting, M E van der Burg, Gabriel Amadasun, M de Boer-Dennert, Miranda Harteveld, Walter J. Loos, I Hudson, G. Stoter, Jaap Verweij	1996	56
15	Topotecan in colorectal cancer: A phase II study of the EORTC early clinical trials group Annals of Oncology ·G.J. Creemers, J. Wanders, Teresa Gamucci, Susanne Vallentin, Luc Dirix, Patrick Schöffski, I Hudson, Jaap Verweij	1995	37
16	926 Pharmacokinetics (PK), clinical pharmacodynamics (PD) and safety of chronic oral topotecan (T), in a phase I study European Journal of Cancer ·Jan H.M. Schellens, John R. Eckardt, Daniel D. Von Hoff, G.J. Creemers, C J Gerrits, Walter J. Loos, I Hudson, Colin Broom, Richard Wyche, Jaap Verweij	1995	4
17	The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience Journal of Hospital Infection ·I Hudson	1994	122
18	Mupirocin resistance The Lancet ·Sang-Hyup Jeon, I Hudson, Richard Wise, H. Rode, Sonia Delaporte-Cerceau, A.J.W. Millar, S. Cywes	1992	2
19	Biotin Labeling of Red Cells in the Measurement of Red Cell Volume in Preterm Infants Pediatric Research ·I Hudson, I. Cavill, Alison Cooke, B M Holland, T. G. Hoy, D Trevett, Thomas L. Turner, C A Wardrop	1990	39
20	Total circulating red cells versus haematocrit as the primary descriptor of oxygen transport by the blood British Journal of Haematology ·John G. Jones, B M Holland, I Hudson, C A Wardrop	1990	53

About I Hudson

I Hudson is a scholar working on Oncology, Reproductive Medicine, Hematology, Neurology and Critical Care and Intensive Care Medicine, having authored 28 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Neutropenia and Cancer Infections (9 papers), Lung Cancer Research Studies (6 papers), Cancer Treatment and Pharmacology (4 papers), Neuroblastoma Research and Treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cardiac Structural Anomalies and Repair (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Reproductive Medicine (664 citations), Obstetrics and Gynecology (243 citations), Oncology (697 citations), Toxicology (44 citations) and Surgery (563 citations). I Hudson has collaborated with scholars based in United Kingdom, Netherlands and Italy. Frequent co-authors include Giorgio Bolis, Jaap Verweij, Colin Broom, Martin Gore, B M Holland, John H. Malfetano, J Carmichael, Robert L. Coleman, N. Davidson and Anderley Gordon. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, The Oncologist, Annals of Oncology and Archives of Disease in Childhood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact